Benefit of splenectomy in distal pancreatectomy for neuroendocrine tumours: multicentre retrospective study.

Date publication

mai 2025

Journal

BJS open

Auteurs

Membres identifiés du Cancéropôle Est :
Pr AYAV Ahmet , Dr FACY Olivier , Pr HEYD Bruno

Tous les auteurs :
Clément E, Addeo P, Sauvanet A, Turco C, Marchese U, Dokmak S, Laurent C, Ayav A, Turrini O, Sulpice L, Souche R, Perinel J, Birnbaum DJ, Facy O, Gagnière J, Schwarz L, Piessen G, Regenet N, Iannelli A, Regimbeau JM, Lenne X, Heyd B, Gaujoux S, El Amrani M, Doussot A,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40357650

Résumé

Distal pancreatectomy is frequently indicated for left-sided pancreatic neuroendocrine tumour (NET). When combined lymphadenectomy is warranted, distal pancreatectomy with splenectomy (DPS) is generally advocated to optimize lymph node dissection. The spleen-preserving distal pancreatectomy (SPDP) may represent an alternative approach. This study aimed to evaluate postoperative and oncological results of distal pancreatectomy with and without splenectomy for pancreatic NET.

Mots clés

Humans, Pancreatectomy, methods, Splenectomy, methods, Retrospective Studies, Male, Female, Neuroendocrine Tumors, surgery, Middle Aged, Pancreatic Neoplasms, surgery, Aged, Lymph Node Excision, Adult, Propensity Score, Treatment Outcome, Organ Sparing Treatments, methods

Référence

BJS Open. 2025 05 7;9(3):